API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.fiercebiotech.com/biotech/nkarta-touts-cell-therapy-effectiveness-specific-lymphodepletion-regiment-durability
https://www.biospace.com/article/crispr-therapeutics-announces-promising-data-for-its-car-t-cancer-therapy/?s=71
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-1-2021-1630499458.pdf
https://www.prnewswire.com/news-releases/cbmg-holdings-novel-anti-cd20-car-t-cell-therapy-shows-promising-safety-and-efficacy-in-relapsedrefractory-b-cell-non-hodgkin-lymphoma-patients-following-relapse-to-an-anti-cd19-car-t-therapy-301310049.html
https://www.prnewswire.com/news-releases/cbmg-holdings-novel-cd19cd20-bi-specific-car-t-cell-product-shows-early-promising-clinical-efficacy-and-favorable-safety-profile-in-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma-301310047.html
https://www.businesswire.com/news/home/20191207005033/en/Imbruvica%C2%AE%E2%96%BC-ibrutinib-Combination-Therapy-Data-Studies-Long-Term/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
https://www.biospace.com/article/unum-plunges-after-fda-places-another-clinical-hold-on-company-asset/
https://www.pharmacompass.com/pdf/news/jiangsu-yew-pharmaceutical-co-ltd-fails-edqm-inspection-1537438043.pdf
http://www.fiercebiotech.com/biotech/juno-notches-positive-data-for-next-line-car-t-jcar017
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203738
https://globenewswire.com/news-release/2016/12/12/896995/0/en/European-Commission-Grants-Marketing-Authorization-for-Arzerra-ofatumumab-in-combination-with-Fludarabine-and-Cyclophosphamide-in-Relapsed-CLL.html
http://www.in-pharmatechnologist.com/Regulatory-Safety/Juno-deaths-CAR-T-experts-suspect-therapy-at-fault-not-the-field
http://www.fiercepharma.com/partnering/does-trump-presidency-mean-changes-for-pharma-marketing-and-advertising
http://www.fiercebiotech.com/biotech/adaptimmune-stock-slides-after-poor-efficacy-forces-it-to-add-fludarabine-to-regimen
https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-co-ltd-yantou-campus-fails-edqm-inspection-1483966941.pdf
http://www.biospectrumasia.com/biospectrum/news/221144/taigen-initiates-clinical-trial-leukemia-drug-china